Daily Digest

stat_news

Germany moving to a 15.5% mandatory rebate tightens pricing and launch economics there, which will compress revenue expectations and likely push pharma to reprioritize launch sequencing, price elsewhere, or insist on volume- or outcome‑based contracts. At the same time, US startups are deliberately hiding early data and program details to avoid fast followers from China, producing fewer public datasets and delayed disclosures. For you: margin pressure in a major EU market changes deal incentives and could reduce near‑term M&A/licensing activity relevant to AI‑discovery firms, while growing secrecy erodes the open-data signals that feed model training and competitor surveillance. Practical responses: bake market‑access scenarios into valuation models, double down on private and synthetic training data, and invest in early IP/registry/clinical‑readout monitoring pipelines.

stat_news

Roche has halted two Huntington’s gene-silencing programs after clinical setbacks — a concrete signal that CNS-targeted RNA‑silencing approaches still struggle to translate into meaningful patient benefit despite good biomarker engagement. For drug-discovery strategy this amplifies two practical takeaways: (1) modality risk matters — delivery, durability, and downstream biology can derail otherwise clean target knockdown; and (2) translational predictivity is a gating problem that remains unsolved. For you at Isomorphic Labs this shifts the landscape in two ways: it likely cools investor appetite and partnership interest in ASO/siRNA CNS startups while increasing demand for small‑molecule or alternative-modality solutions and for ML that better predicts clinical efficacy from preclinical and early biomarker data. Watch for the trial’s mechanistic readouts (target knockdown vs clinical endpoints) — they’ll guide where computational models can add the most value.

biopharma_dive

ARPA-H’s $160M push to establish a roadmap for bespoke gene‑editing therapeutics will materially accelerate demand for computational tooling that can turn patient‑level genotypes into safe, optimised edits. Expect near‑term priorities around standardized data pipelines, off‑target prediction, delivery vector design, and regulatory‑grade validation — all areas where model accuracy, interpretability, and inference efficiency matter. For someone building ML platforms for drug discovery, this is a funding signal to position for consortium calls, contribute to emerging data standards, and productize scalable, auditable design and safety models. Separately, a migraine drug beating a Botox rival and leadership changes at a mid‑stage biotech underscore commercial pressure to translate platform outputs into nearer‑term, de‑risked assets and partnerships — useful context for BD and competitive mapping.

biopharma_dive

GSK and Hansoh’s ADC showing an overall survival benefit against B7‑H3 in lung cancer is practical validation that B7‑H3 is a clinically actionable ADC target, not just a preclinical curiosity. That lowers biological risk across a growing field of B7‑H3 programs and will accelerate investment, partnerships, and competitor ADC/bispecific launches because lung cancer is a high‑value indication. For you at Isomorphic, the readout increases commercial demand for computational capabilities that de‑risk ADC programs: epitope selection, antibody design, linker/payload optimization, PK/target engagement prediction, and biomarker‑driven patient stratification. Watch for rapid follow‑on clinical programs and potential data/partnering opportunities—this is the kind of target validation that can open short paths to collaborations or licensing for platform teams.

Allison Creed · openalex

Metaphor choices materially shape how domain information is perceived across cultures: anthropomorphic framing (e.g., “wine is a person”) is much more consistently interpreted across Australian and Chinese educators than other metaphor families, while object-, artefact-, and spatially-framed metaphors vary more and can mislead. Two practical takeaways: for cross‑border scientific or commercial communication, favor metaphor classes with higher cross‑cultural congruence (personification) or validate metaphors empirically in target audiences; for NLP/annotation work, use structured metaphor identification (MIPVU) and semantic tagging to capture thematic families and spatial/temporal properties so models don’t propagate culturally contingent framings. For AI-driven drug discovery and stakeholder-facing outputs, unintended emotive/metaphoric framing can bias perception of molecules, risks, or efficacy—test and control language systematically.

stat_news

Sean Kaufman, nominated to lead federal emergency preparedness, has publicly questioned infant hepatitis B vaccination and the long-discredited vaccine–autism consensus. Placed within an HHS under RFK Jr., his selection raises a real prospect of policy shifts that could politicize vaccine programs, slow or redirect federal procurement and preparedness funding, and complicate public–private collaboration on countermeasures. For someone at an AI-driven drug-discovery company, the risk is pragmatic: greater regulatory and funding unpredictability for vaccine or biologics programs, increased scrutiny or reputational risk for firms partnering with U.S. agencies, and potential limits on access to government-held public-health data and trial channels. Watch the confirmation, ASPR guidance changes, and any funding or data-access signals that could affect partnerships or program timelines.

G. M. Monirul Alam · openalex

Riverbank erosion in Bangladesh is systematically stripping arable land and driving entrenched food insecurity—char (sandbar) households are the worst affected, with over half of surveyed households food-insecure and average per-capita calories ~12% below minimum. Key determinants of household resilience and food security are household size, education, livestock ownership, non-farm income and access to healthcare; coping strategies center on crop diversification, homestead gardening and migration but are constrained by lack of credit and information. Policy levers with high payoff include targeted cash/credit transfers, infrastructure, and coordinated health and agricultural programs. For you: this is a clear, high-impact use case for geospatial and remote-sensing ML (predicting erosion, targeting interventions) and for data-driven allocation of limited public-health and supply-chain resources—an opening for applied ML / startup partnerships that bridge climate risk and health delivery.

stat_news

The FDA quietly delayed enforcement of a planned ban on a class of electric-shock devices, effectively giving manufacturers more time to comply and keeping contested products on the market while legal and data submissions continue. Short-term this eases pressure on medtech firms and investors, but it also prolongs patient exposure to devices with unresolved safety concerns and leaves regulatory risk unsettled. For you: this isn’t directly about drug discovery, but it’s a useful signal about FDA behavior—agencies may grant breathing room for contentious technologies rather than forcing abrupt exits. That affects regulatory timelines, M&A and partnership diligence for AI-driven life‑science startups that intersect with hardware or high-scrutiny clinical claims, and should be modeled into risk and go-to-market plans.

Jonathan Watts · guardian

Human-driven greenhouse‑gas emissions are amplifying heatwaves far beyond the global mean rise — extremes are increasing faster (e.g., southern England heatwaves are ~3°C hotter even though global average is ~1°C) and natural factors like El Niño only amplify, not cause, the trend. For geospatial modelling, infrastructure and portfolio risk this means updating baselines and tail‑risk assumptions now: expect more frequent extreme-heat events that affect supply chains, workforce/clinical operations, and climate-sensitive ML models.

Angelique Chrisafis in Montargis · guardian

An appeals court upheld Marine Le Pen’s conviction for siphoning EU funds but shortened her ineligibility, allowing her to declare a presidential bid while polling shows her still competitive as RN consolidates local gains. Her resilience—voters willing to overlook corruption in favor of anti-immigration and anti-establishment change—raises political tail risks for EU policymaking and investor sentiment in France/EU, so monitor potential impacts on euro-market volatility and exposures in UK/EU equities and policy-sensitive sectors.

William Fotheringham · guardian

The Tour is already deploying heavy mitigation—tons of ice, personalized electrolyte regimens and cooling tech—but ongoing warming will force more structural responses (route/date changes, stricter carbon/safety constraints and sponsor scrutiny). This is a live case where geospatial planning, supply‑chain engineering and real‑time physiological telemetry + individualized models are being applied at scale to manage climate risk—relevant to route optimization, heat‑mapping and operational ML systems you work on.

bbc_world

A cohort of crypto billionaires is constructing private, token‑governed jurisdictions that effectively let wealth buy political voice and bypass traditional democratic and legal safeguards. For Nathan this raises practical risks: startups, talent, and capital may migrate to these regulatory havens, altering where AI/biotech companies incorporate, how IP and data are governed, and who holds de facto control in consortiums or platform partnerships—so track incorporations, DAO governance models, and legal exposure when evaluating partners or funding sources.

bbc_world

A 1,000 km‑wide typhoon Bavi is heading toward Taiwan and southeastern China after landslides in the Philippines killed at least 15; it's forecast to be among the strongest storms in decades. Anticipate disruption to ports, freight and coastal factories (including semiconductor supply chains), plus short‑term volatility in Asian markets and logistics delays for imports/exports. Track operational notices from fabs and major ports, freight route rerouting, and emergency measures that could affect supply timelines and market exposure.

bbc_world

Apple's lawsuit alleging OpenAI stole hardware trade secrets marks a step from rivalry to litigation over AI talent and infrastructure; expect tougher NDAs, more aggressive employee non-competes, and vendor caution. For ML engineers and startups this increases hiring/legal risk and could slow OpenAI's in‑house hardware timeline, shifting talent and supplier dynamics that affect infrastructure choices and recruitment markets.

Yifan Wu, Lizhu Zhang, Yuhang Zhou, Mingyi Wang · hf_daily_papers

A lightweight, learned memory agent that runs alongside an action model and selectively injects reminder snippets substantially reduces “behavioral state decay” in long-horizon tasks—improving pass@1 by ~8.3pp and ~6.8pp on two benchmarks. Selective, policy-driven intervention outperforms passive bank exposure, always‑on insertion, advisor-only prompts, and generic retrieval, and training a memory policy (Qwen3.5-27B via SFT+GRPO) is both feasible and partially transferable. For you: this is a practical, plug‑and‑play architectural pattern to keep decision-relevant facts salient without blowing up context windows—useful for multi-step drug design or lab workflows where past experiment notes, diagnoses, and subgoals must influence future actions. Expect tradeoffs: an extra model and latency/compute for policy training versus clearer, more reliable long-horizon decisions and better sample efficiency.

sebastian_raschka

Having 72 plausible GPT‑5.6 configurations spotlights a practical problem: flexibility becomes a deployment tax. Pick a small set of intentional defaults instead of treating every knob as a new model. For production work (drug discovery inference, interactive R&D tools) prefer a single, inference‑efficient baseline: a moderately large dense model checkpoint with FP16/8 quantization, deterministic decoding, and a context length tuned to typical retrieval windows; reserve larger context/parameter or MoE variants for gated, high‑cost pipelines. Version and expose configuration as a first‑class API (train vs inference profiles), measure cost/token and calibration under realistic prompts, and automate switching rules based on task latency and fidelity needs. This reduces reproducibility risk, simplifies benchmarking, and bounds costs for downstream experiments.

reddit_singularity

A recent SimpleBench run shows a noticeable performance regression in a recent OpenAI model update on basic reasoning and prompt-following tasks. That suggests model changes (RLHF tuning, safety filters, tokeniser or pretrain-corpus updates) introduced a behavioural shift that breaks previously working, simple prompts. For production ML: treat this as a reminder that model upgrades can silently degrade core capabilities and that black‑box providers may change behaviour without predictable trade-offs. For your drug-discovery pipelines and LLM-driven tooling, add a small, focused regression suite of domain‑specific prompts (chemical SMILES handling, assay interpretation, constrained reasoning) and gate upgrades on pass/fail thresholds; consider Canarying new models, maintaining pinned versions for critical pipelines, and budgeting time to re-fine‑tune or calibrate if a provider rollout reduces utility.

reddit_singularity

White House is reportedly weighing an executive order aimed at open-source AI — potentially introducing controls around model release, provenance, licensing and security vetting. That would create legal and operational uncertainty for teams that rely on public weights, community checkpoints and permissive tooling: expect stricter release procedures, slower public dissemination of models, and potential fragmentation between “vetted” US-hosted models and freer foreign-hosted variants. For a drug‑discovery ML engineer, this raises two immediate impacts: (1) reduced access to baseline weights and community replication artifacts that accelerate prototyping and benchmarking, increasing build time and cost; (2) a new compliance/hosting opportunity — vendors offering vetted private hosting, provenance tooling, and model-auditing services could become essential. Actionable next steps: inventory external model/dependency sources, tighten provenance logging, and follow policy drafts to reassess open-weight sharing plans.

reddit_singularity

A high-profile IP lawsuit between Apple and OpenAI signals growing legal scrutiny over provenance of training data and potential transfer of proprietary know-how via models. Expect faster tightening of contractual clauses, stricter data-use audits, and demand for provenance tooling across ML pipelines — especially where corporate secrets or regulated IP are involved. For teams working on IP-sensitive models (e.g., drug discovery), this increases the importance of documented data lineage, hardened access controls, and legal-reviewed model sharing policies; it also raises the bar for partnerships with generalist LLM vendors. Operationally, budget for compliance, legal risk modeling, and reproducible dataset snapshots will become functionally necessary, and open or lightly-scrubbed pretraining datasets may face renewed pushback from enterprise partners and regulators.

reddit_singularity

Boko Haram is reportedly using frontier AI (LLMs and generative tools) to scale multilingual propaganda, automate recruitment, craft persuasive micro-targeted messaging, and exploit mapping/geospatial data for operational planning. The key risk is the dramatic lowering of the technical barrier: powerful open models and low-cost inference let small, distributed groups do tasks that previously required specialist teams. For an ML engineer this underlines immediate priorities: stronger provenance and watermarking, stricter model access controls, telemetry for anomalous fine-tuning/use patterns, and collaboration with platform and geospatial teams to detect misuse (e.g., suspicious map queries or routing). Expect increased regulatory scrutiny and demand for production-grade safety tooling that can be integrated into inference stacks and API platforms.

Ruiqi Shen, Chang Liu, Henghui Ding · hf_daily_papers

SAM-MT converts SAM2 into a real-time, interactive multi-target video segmenter that keeps latency fixed as target count grows (reported >36 FPS with 10 targets). It does this by representing each object as an explicit query alongside a shared global representation, using decoupled masked attention to avoid cross-target interference and a sparse memory for stable temporal state, plus practical occlusion/overlap handling. For an ML engineer this is notable both as an architectural recipe for bounded-latency, multi-entity inference and as a practical tool: it enables scalable interactive annotation and live multi-object monitoring (e.g., traffic/remote-sensing pipelines or microscopy time-lapse), and suggests transferable techniques for per-entity state management and attention sparsity when building low-latency production systems.

latent_space

OpenAI’s GPT‑5.6 superapp rollout made visible a deliberate shift: they’ve removed the explicit model picker in favor of server-side routing and have just acquired Statsig to weaponize experimentation. The immediate consequence is confusing UX and unstable behavior for end users and integrators as options and routing change dynamically. For engineers that matters: expect opaque model-variant selection, more runtime switching, and silent behavior changes driven by feature flags — so pin versions, tighten CI/regression tests, and add observability for latency/cost/semantic drift. The Statsig move speeds iteration but increases the risk of unexpected API-side regressions; if you rely on LLMs in pipelines (e.g., codegen, data curation, inference hooks), audit configs and add deterministic fallbacks.

Md. Shakhoyat Rahman Shujon, MD Jahid Hasan Jim, Md. Milon Islam, Md Rezwanul Haque · hf_daily_papers

PAST-TIDE reframes stance detection as “statement tuning”: map label words into a pre-trained MLM head (a verbalizer) instead of adding a random classifier, then reinforce those label representations with prototypical contrastive learning (learnable class prototypes that remove the need for huge contrastive batch sizes) and a topic-conditional layer norm to stabilize cross-topic performance. It hits ~0.74–0.75 macro-F1 on a low-resource Arabic benchmark with minimal architectural change. Why it matters to you: the pattern—reuse the MLM head + learnable prototypes + conditional normalization—offers a lightweight, batch-size-robust recipe for adapting foundation models in low-data, domain-shift settings (think new assays, rare targets, or geographic domain shifts in mapping). Useful for faster prototyping, fewer randomly initialized params, and contrastive training without large infrastructure tradeoffs; caveat: verbalizer design and label semantics still matter.

reddit_singularity

Roughly four in ten longform LinkedIn posts are now AI-generated, which is shifting professional feeds from original thought leadership toward high-volume, low-friction content. That undermines signal for hiring, partnership outreach, and technical reputation while creating a short-term market for provenance, verified‑human tiers, and detection services — though adversarial editing and undetectable model outputs will limit those fixes. For you: expect more noise when scouting talent or gauging community opinion; differentiate by publishing reproducible, evidence-backed posts (data, code, benchmarks) and by leaning on verifiable artifacts rather than tone. Also track platform policy and watermarking efforts—these will affect how scientific claims and recruiting messages are received and may influence external comms strategy.

abnormal_returns

Real yields at multi‑decade highs while equities make up a record share of U.S. household wealth — that’s a classic recalibration moment: fixed income finally offers genuine, low-volatility real returns, raising the case for trimming equity exposure or redirecting new contributions into tax‑efficient bond allocations (ISA/SIPP) rather than buy‑and‑hope. Passive dominance means most active managers won’tjustify higher fees, so if chasing outperformance focus on disciplined factor or concentrated tilts, or on alternative niches where fees are earned (but size and liquidity matter). Private‑credit allocations look procyclical — banks can both provide and withdraw capacity, so size exposures with liquidity buffers. Separately, cross‑border listings and mega IPOs compress VC liquidity and signal where capital is flowing; and data‑centre siting/environmental rules will increasingly shift marginal AI compute geography — monitor memory markets and regional capex for ML infrastructure costs and latency implications.

wealth_common_sense

Earnings growth is accelerating, corporate margins remain elevated, and market leadership is broadening beyond mega-cap tech into cyclicals and smaller caps — a setup more consistent with a fundamentally driven rally than a narrow liquidity pump. For a FIRE-minded, tax-aware investor in the UK, that argues for maintaining or modestly increasing equity exposure inside ISAs/SIPPs via broad, low-cost ETFs to capture the widening breadth while avoiding single-stock concentration. Tactical options: small, disciplined tilts toward value/cyclicals or small caps if you have risk capacity and strict sizing rules; use staggered buys and keep a cash/short-duration bond buffer because margins can reverse quickly if macro or rates surprise. Rebalance and harvest gains tax-efficiently rather than chasing momentum.

venturebeat

57% of enterprises have traced confidently wrong agent answers back to missing or inconsistent business context, yet only ~25% run a governed ‘agentic’ context layer in production and many more haven’t started. Vendors are racing competing architectures (catalog-driven metadata, DB-edge memory, precompiled metadata, two-layer managed/inferred context, unified transactional memory), so choosing a platform now is as much about architectural trade-offs and lock-in as features. For production ML systems—especially in regulated, knowledge-heavy domains like drug discovery—this argues for a single curated semantic layer (ontology + provenance + live sync) that agents query, robust test harnesses for stale-context failures, and telemetry that ties model outputs to the context snapshot used. Prioritise verifiable provenance, deterministic ingestion, and lineage to avoid silent, confident failures.

venturebeat

OpenAI has productized an always-on, cloud-hosted agent (powered by GPT-5.6) that can autonomously execute multi-step workflows across Gmail, Slack, Calendar, GitHub and files via MCP-based plugins. The architectural bet — a persistent VM in OpenAI’s control — pushes agent functionality into the cloud, shifting costs/latency and centralizing trust and access control. For engineering teams this accelerates "agentization" as a standard service (and raises the bar for integration and UX), but it also amplifies security/compliance risks: any org with sensitive IP (drug designs, patient data, proprietary maps) must decide whether to permit cloud agents or build internal equivalents. For Isomorphic Labs this is both pressure and opportunity — watch plugin/APIs, auth/enterprise controls, cost model, and the MCP ecosystem: either adopt vetted integrations or double down on internal agent infrastructure to retain custody of models and data.

hacker_news

Treat maintainability as a first-class product requirement: write code so the next engineer (or future you) can reason about intent, not implementation details. Concretely: prefer explicit, intention-revealing names and small, well-documented modules over clever one-liners; write tests for behavioral invariants (data shape, training convergence, API contracts) rather than fragile implementation specifics; keep PRs small, descriptive, and self-contained; and schedule short, frequent refactors instead of infrequent large rewrites. For ML teams, add reproducible pipelines, clear experiment metadata, and data-lineage hooks so model behavior is debuggable long after the training run. Make code reviews check for cognitive load (can someone unfamiliar with the area follow this in 10 minutes?) and bake these practices into onboarding, CI, and architecture decisions to reduce tech debt and speed iteration.

the_next_web

AI adoption is shifting the failure mode from isolated model drift to systemic drift — emergent changes in how models, data pipelines, orchestration layers and external services interact. Practically, that means observability must move from per-model metrics to dependency-aware, causal monitoring (change propagation, representation-level drift, orchestration latencies, and cross-component SLOs), plus stronger provenance and automated rollback/mesh policies. For Nathan: Isomorphic’s drug-discovery stacks are classic multi-component systems (multiple models, assays, lab automation, data curation), so blind spots between components are the highest risk to scientific validity and throughput. Immediate actions: build a dependency graph and lineage for experiments, instrument inter-component signals (feature distributions, queue times, calibration drift), add end‑to‑end synthetic tests and SLOs, and evaluate startup tooling that detects systemic drift as a platform feature.

venturebeat

Enterprises are sitting on heavily underused GPU capacity (86% report ≤50% utilization) while simultaneously moving to buy more cloud or alternative accelerators — and most lack rigorous per-workload cost telemetry. At the same time, deployed “agents” are mostly single-prompt chatbots; true multi-step agents are rare. Practical takeaway for infra-first ML teams: instrument before you buy. Add per-job/per-agent billing tags, fine-grained cost & latency telemetry, and per-agent budgets/quotas so you can measure ROI and enforce ceilings. Short-term wins include better scheduling, batching, multi-tenancy, and SLO-aware autoscaling to raise utilization; medium-term, invest in an orchestration/control plane (identity, evaluation, cost telemetry) to safely scale multi-step agent workflows for inference-heavy drug-discovery pipelines.

venturebeat

Enterprises are pushing agents into production faster than they can prove reliability: teams grant autonomous release paths while automated tests repeatedly fail to predict real-world failures. Treat capability vs. consistency as separate metrics — prioritize repeatability, scenario variation, tool-failure simulation and ‘every-run’ success rates, not just single-run capability. Operationally, incidents must be converted into permanent regression tests, with field testing, canaries, post-deploy monitoring and clear escalation playbooks. For platform and ML infra, the takeaway is concrete: build agent-centric observability (action lineage, tool-call success/failure, state diffs), risk-tier autonomy gates, and automated pipelines that inject context and stochasticity into pre-release suites. If you’re owning agent rollouts or infra, expect a near-term budget shift from model training to control, orchestration and verification layers.

netflix_tech

Netflix demonstrates a practical, low-risk way to measure the causal value of personalization: build a day-by-day behavioral choice model that leverages natural algorithmic exploration as quasi-random variation, then validate model-implied substitution with small, targeted salience nudges (A/B tests). That combination isolates true recommender uplift from users’ baseline preferences without turning personalization off, and yields actionable estimates of substitution patterns and net incremental engagement. For platform teams this is a useful blueprint: log exploration decisions, treat algorithmic randomness as an instrument, and use lightweight nudges to ground-truth counterfactuals. Applies directly to any ML-driven prioritization system (e.g., drug-candidate ranking or geospatial suggestions) where fully disabling personalization is infeasible but understanding uplift and substitution is critical for downstream decisions.

github_engineering

GitHub replaced Copilot Code Review’s bespoke repo-exploration tools with shared CLI primitives (grep/glob/view) and initially saw reviews become more expensive and less effective. The problem wasn’t the tools themselves but the instruction/workflow layer: the new primitives changed how the agent called tools and gathered context, so existing prompts were a mismatch. Rewriting the reviewer instructions to match how humans actually scan PRs flipped the regression into a win — roughly 20% lower average review cost at the same quality. Why this matters to you: when you migrate agents or standardize toolchains, behavioral regressions are likely unless you treat prompt/workflow “contracts” as part of the API. Practical takeaways: add behavior-level regression tests, instrument per-tool-call costs and call patterns, A/B prompt/instruction variants, and iterate small before wide sharing of agent tools.

cloudflare_blog

Cloudflare added a cloud-region hint to Smart Tiered Cache so origins behind public-cloud anycast or regional frontends (AWS, GCP, Azure, Oracle) can be mapped to the correct region and get a single optimal upper-tier data center. Practically, that restores the cache-concentration benefits lost when origin IPs look ambiguous: higher hit ratios, fewer origin connections, lower tail latency and bandwidth/cost savings on origin pulls. For an ML/platform engineer, this matters for model-serving and artifact-hosting patterns that sit behind cloud frontends—less origin load during cache churn, more predictable routing for multi-region deployments, and an easy knob to improve edge cache efficiency without changing origin topology. If you use Cloudflare in front of cloud-hosted inference APIs or object storage, add region hints and reassess cache metrics and origin billing.

bytebytego

ByteByteGo is kicking off Cohort 7 of its live, cohort-based "Becoming an AI Engineer" course tomorrow — a reminder that structured, short-form applied AI training remains a fast pipeline for junior-to-mid talent. For you, this is less about signing up and more about opportunity: these cohorts are useful funnels for hiring or sponsorship, a lightweight way to upskill a junior engineer on production ML patterns, and a quick market signal about what practical skills (MLOps, model deployment, efficiency hacks) are being taught to entry-level candidates. If hiring, try to get access to the cohort’s demo day or materials to assess calibration to Isomorphic’s needs (drug-discovery model types, data provenance, inference efficiency). If not hiring, consider recommending it to a mentee or using its syllabus as a checklist for internal training gaps.